Genetics
Home › Medical research › Crohn's disease
Insufficient evidence

Crohn's disease & cannabis

A Cochrane review could not draw conclusions on safety or efficacy. Some patients report symptom and quality-of-life improvement, but there is no reliable effect on clinical remission or objective inflammation — and observational data associate cannabis with higher surgery risk.

Sources: Cochrane Crohn's (CD012853)

Most-studied cannabinoids

THCCBD

Safety & cautions

May relieve symptoms while masking underlying inflammation; higher surgery risk in some data.

Clinical research below concerns cannabis or cannabinoids, not evidence that a named cultivar treats a condition.

Help us build this responsibly

This page reflects the cited published clinical evidence, and it is a work in progress. Areto is committed to expanding and refining it as new research emerges — so it can genuinely help medical patients make informed choices. If you are a clinician, researcher, or patient with peer-reviewed sources to add, email us at genetics@areto.tech.

Areto Genetics is an educational cannabis catalog. Nothing here is medical advice, and no strain is proven to treat, cure, or prevent any disease. Cannabis affects people differently and carries real risks. Talk to a qualified healthcare provider before using cannabis for any condition — especially if you are pregnant or breastfeeding, an adolescent, taking other medications, or have a heart, liver, or psychiatric condition.